Cubist Systematic Strategies’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,683
| Closed | -$3.85M | – | 1453 |
|
|
2024
Q1 | $3.85M | Buy |
55,683
+21,939
| +65% | +$1.52M | 0.02% | 612 |
|
|
2023
Q4 | $1.86M | Buy |
33,744
+5,160
| +18% | +$285K | 0.01% | 855 |
|
|
2023
Q3 | $1.66M | Buy |
28,584
+25,114
| +724% | +$1.46M | 0.01% | 852 |
|
|
2023
Q2 | $187K | Sell |
3,470
-3,465
| -50% | -$187K | ﹤0.01% | 1689 |
|
|
2023
Q1 | $275K | Buy |
+6,935
| New | +$275K | ﹤0.01% | 2078 |
|
|
2022
Q4 | – | Sell |
-8,751
| Closed | -$281K | – | 3249 |
|
|
2022
Q3 | $281K | Buy |
+8,751
| New | +$281K | ﹤0.01% | 2811 |
|
|
2022
Q1 | – | Sell |
-25,869
| Closed | -$1.19M | – | 3513 |
|
|
2021
Q4 | $1.19M | Buy |
+25,869
| New | +$1.19M | 0.01% | 1787 |
|
|
2020
Q3 | – | Sell |
-12,499
| Closed | -$404K | – | 2476 |
|
|
2020
Q2 | $404K | Buy |
+12,499
| New | +$404K | 0.01% | 1700 |
|
|
2020
Q1 | – | Sell |
-6,105
| Closed | -$376K | – | 2147 |
|
|
2019
Q4 | $376K | Sell |
6,105
-1,719
| -22% | -$106K | 0.01% | 1710 |
|
|
2019
Q3 | $570K | Buy |
+7,824
| New | +$570K | 0.01% | 1235 |
|
|
2019
Q1 | – | Sell |
-7,805
| Closed | -$351K | – | 2227 |
|
|
2018
Q4 | $351K | Buy |
+7,805
| New | +$351K | 0.02% | 1171 |
|
|
2018
Q2 | – | Sell |
-18,027
| Closed | -$1.05M | – | 1770 |
|
|
2018
Q1 | $1.05M | Buy |
+18,027
| New | +$1.05M | 0.06% | 413 |
|
|
2016
Q1 | – | Sell |
-4,744
| Closed | -$214K | – | 1593 |
|
|
2015
Q4 | $214K | Buy |
+4,744
| New | +$214K | 0.01% | 1316 |
|
|
2015
Q3 | – | Sell |
-17,100
| Closed | -$1.06M | – | 1853 |
|
|
2015
Q2 | $1.06M | Buy |
+17,100
| New | +$1.06M | 0.05% | 532 |
|
|
2015
Q1 | – | Sell |
-3,651
| Closed | -$206K | – | 1875 |
|
|
2014
Q4 | $206K | Buy |
+3,651
| New | +$206K | 0.01% | 1491 |
|